Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Interleukin-13 IgGFc fusion protein

X
Drug Profile

Interleukin-13 IgGFc fusion protein

Alternative Names: IL-13 antagonist - Wyeth; IL-13-α-2-IgGFc fusion protein; Interleukin-13 antagonist - Wyeth; sIL-13R-α-2-Fc

Latest Information Update: 03 Oct 2011

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Wyeth
  • Class Antiasthmatics
  • Mechanism of Action Interleukin 13 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Allergic asthma; Hepatic fibrosis

Most Recent Events

  • 17 Feb 2006 No development reported - Preclinical for Allergic asthma in USA (unspecified route)
  • 17 Feb 2006 No development reported - Preclinical for Hepatic fibrosis in USA (unspecified route)
  • 29 Jan 2003 Genetics Institute is now called Wyeth

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top